Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mereo BioPharma Group (MREO) Asset Utilization Ratio: 2021-2025

Historic Asset Utilization Ratio for Mereo BioPharma Group (MREO) over the last 2 years, with Sep 2025 value amounting to -0.01.

  • Mereo BioPharma Group's Asset Utilization Ratio fell 8238.34% to -0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was -0.01, marking a year-over-year decrease of 8238.34%. This contributed to the annual value of -0.02 for FY2024, which is 113.80% down from last year.
  • Mereo BioPharma Group's Asset Utilization Ratio amounted to -0.01 in Q3 2025, which was up 62.89% from -0.01 recorded in Q2 2025.
  • In the past 5 years, Mereo BioPharma Group's Asset Utilization Ratio registered a high of 0.15 during Q1 2024, and its lowest value of -0.04 during Q4 2021.
  • In the last 2 years, Mereo BioPharma Group's Asset Utilization Ratio had a median value of -0.01 in 2025 and averaged 0.01.
  • Data for Mereo BioPharma Group's Asset Utilization Ratio shows a maximum YoY plummeted of 8,238.34% (in 2025) over the last 5 years.
  • Quarterly analysis of 4 years shows Mereo BioPharma Group's Asset Utilization Ratio stood at -0.04 in 2021, then reached -0.01 in 2022, then reached -0.02 in 2024, then slumped by 8,238.34% to -0.01 in 2025.
  • Its last three reported values are -0.01 in Q3 2025, -0.01 for Q2 2025, and -0.02 during Q1 2025.